Lv4
715 积分 2021-06-04 加入
Translational PBPK/PD modeling in drug discovery: A CRO perspective
5天前
已完结
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
16天前
已完结
Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects
16天前
已完结
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
16天前
已完结
Functional and Physiological Implications of Oligopeptide Transporters: Potential Targets for Pharmacological Interventions
19天前
已完结
Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice
21天前
已完结
Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate β-catenin
21天前
已完结
Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia
26天前
已关闭
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
26天前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
27天前
已完结
皖公网安备34019202002308
